{"url_path":"/sec/adil/8-k/2026-06-11/item-2-03","section_key":"item-2-03","section_title":"Item 2.03 Creation of a Direct Financial","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-11","source_url":"https://www.sec.gov/Archives/edgar/data/1513525/0001213900-26-067711-index.html","accession_number":"0001213900-26-067711","cik":"0001513525","ticker":"ADIL","issuer_name":"ADIAL PHARMACEUTICALS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1513525/0001213900-26-067711-index.html","primary_entity_key":"0001513525","primary_entity_name":"ADIAL PHARMACEUTICALS, INC."},"word_count":54,"has_tables":true,"body_markdown":"**Item 2.03 - Creation of a Direct Financial\nObligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.**\n\n \n\nThe information\ncontained in Item 1.01 of this Current Report regarding the Company’s guarantee of the payment of the Azora Notes upon closing of\nthe Merger is incorporated by reference into this Item 2.01."}